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The human immunodeficiency virus (HIV) is currently
ranked sixth in the worldwide causes of death [1]. One
treatment approach is to inhibit reverse transcriptase
(RT), an enzyme essential for reverse transcription of
viral RNA into DNA before integration into the host
genome [2]. By using non-nucleoside RT inhibitors
(NNRTIs) [3], which target an allosteric binding site,
major side effects can be evaded. Unfortunately, high
genetic variability of HIV in combination with selection
pressure introduced by drug treatment enables the virus
to develop resistance against this drug class by develop-
ing point mutations. This situation necessitates treat-
ment with alternative NNRTIs that target the particular
RT mutants encountered in a patient.
Previously, proteochemometric approaches have
demonstrated some success in predicting binding of par-
ticular NNRTIs to individual mutants; however a struc-
turebased approach may help to further improve the
predictive success of such models. Hence, our aim is to
rationalize the experimental activity of known NNRTIs
against a variety of RT mutants by combining molecular
modeling, long-timescale atomistic molecular dynamics
(MD) simulation sampling and ensemble docking. Initial
control experiments on known inhibitor-RT mutant
complexes using this protocol were successful, and the
predictivity for further complexes is currently being
evaluated. In addition to predictive power, MD simula-
tions of multiple RT mutants are providing fundamental
insight into the dynamics of the allosteric NNRTI bind-
ing site which is useful for the design of future
inhibitors. Overall, work of this type is hoped to contri-
bute to the development of predictive efficacy models
for individual patients, and hence towards personalized
HIV treatment options.
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